Assessment and treatment of attention-deficit/hyperactivity disorder: part 2

Pediatr Ann. 2015 Apr;44(4):160-8. doi: 10.3928/00904481-20150410-11.

Abstract

Attention-deficit/hyperactivity disorder (ADHD) is the most common neurobehavioral disorder of childhood. In part 1 of this article, information regarding primary care assessment of ADHD was presented. Part 2 focuses on best practice guidelines for treatment once the diagnosis has been established. For most children, successful treatment of ADHD requires a multicomponent approach comprised of patient and family psychoeducation, use of medications approved by the US Food and Drug Administration (eg, stimulants) and/or behavioral interventions, and management of any psychiatric comorbid conditions. Furthermore, as ADHD is a chronic illness, primary care physicians will need to frequently reassess their patients and make treatment adjustments as needed.

MeSH terms

  • Adolescent
  • Adrenergic Uptake Inhibitors / therapeutic use
  • Adrenergic alpha-Agonists / therapeutic use
  • Atomoxetine Hydrochloride / therapeutic use
  • Attention Deficit Disorder with Hyperactivity / diagnosis*
  • Attention Deficit Disorder with Hyperactivity / drug therapy*
  • Behavior Therapy / methods
  • Central Nervous System Stimulants / therapeutic use
  • Child
  • Child, Preschool
  • Humans
  • Methylphenidate / therapeutic use

Substances

  • Adrenergic Uptake Inhibitors
  • Adrenergic alpha-Agonists
  • Central Nervous System Stimulants
  • Methylphenidate
  • Atomoxetine Hydrochloride